Patients with presyncope and those with syncope in the ED have similar 30‑day serious cardiac outcomes, although patients ...

Weekly hydrocolloid dressings were comparable to a daily petroleum-based regimen for patient-reported scar appearance after ...

Recent study met primary end point of reduction of numeric rating scale pain intensity in double-blind 12-week treatment phase ...

CNW/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved LYVDELZI (seladelpar) for the ...

Cannabis users experienced similar transplant evaluation and posttransplant outcomes as nonusers, indicating cannabis use ...

Private equity's $11 trillion industry faces its biggest crisis as IPO exits crash 46% and millions of retirees feel the ...

(Head of Commercial: Mike Petroutsas, "Astellas") today announced final overall survival (OS) results from the Phase 3 EMBARK study evaluating XTANDI ® (enzalutamide), in combination with leuprolide ...

The EVEREST trial directly compared biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma, and found that dupilumab (Dupixent) was superior to ...

Sanofi SNY announced that the phase II ElevAATe study, which evaluated its pipeline candidate, efdoralprin alfa, for the ...

Objectives First, investigate whether a long compared with a short abstract decreases readers’ attention. Second, investigate ...

If you don't have the cash for a second home, you may still have options at your disposal to buy another property, such as ...